Cases & Deals

  • Home
  • Practices
  • Theranexus raises €3.6 million in private placement

Share

Theranexus raises €3.6 million in private placement

October 2014

Client(s) Theranexus SAS

Jones Day represented Theranexus SAS, a provider of psychiatric disorders medical treatments, in connection with is issuance of €3.6 million of Convertible Preferred Stock in a private placement to funds managed by Auriga Partners, Sofimac, CEA Investissement, and Rhône-Alpes Création.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.